Integrative histopathological and immunophenotypical characterisation of the inflammatory microenvironment in spitzoid melanocytic neoplasms
Open Access
- 24 September 2020
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 78 (4) , 607-626
Abstract
Aims: The role of inflammation in conventional cutaneous melanoma has been extensively studied, whereas only little is known about the inflammatory microenvironment and immunogenic properties of spitzoid melanocytic neoplasms. The composition of infiltrating immune cells and the architectural distribution of the inflammation, in particular, are still obscure. This is the first study, to our knowledge, to systematically characterise the inflammatory patterns and the leucocyte subsets in spitzoid melanocytic lesions.Methods and results: We examined 79 spitzoid neoplasms including banal Spitz naevi (SN, n = 50), atypical Spitz tumours (AST, n = 17) and malignant Spitz tumours (MST, n = 12) using histopathological analysis and immunohistochemistry. Spitzoid melanocytic lesions showed a high frequency (67.1%, n = 53 of 79) of inflammation. Four inflammatory patterns were identified according to architectural composition, distribution and intensity of inflammation. The majority of the inflammatory infiltrate corresponded to CD3+/CD8+ T lymphocytes (56.1%), followed by CD3+/CD4+ T cells (35.7%) and CD68+ histiocytes (20.3%). CD3+/TIA‐1+ cytotoxic T lymphocytes constituted 3.7% of inflammatory cells. Rarely, CD3+/ granzyme B+ cytotoxic T lymphocytes (2.7%) and CD138+ plasma cells (0.5%) were detected in the infiltrating immune cells. There was no significant difference in the inflammatory cellular composition among the spitzoid melanocytic subgroups (SN versus AST versus MST).Conclusion: Our findings demonstrate that Spitz tumours are highly immunogenic lesions. Inflammation with the presence of lymphocytic aggregates predominated in SN, but was not distinctive for this melanocytic category. A strong and intense inflammation was suggestive of an underlying malignancy. The infiltrating cytotoxic T lymphocyte subsets in Spitz tumours deserve further investigation in larger study cohorts to elucidate prognostic and immuno‐oncological therapeutic relevance.Keywords
Funding Information
- Maastricht Universitair Medisch Centrum
This publication has 67 references indexed in Scilit:
- Lymphoid neogenesis in melanomaOncoImmunology, 2013
- The determinants of tumour immunogenicityNature Reviews Cancer, 2012
- Spitz Nevus in a Hispanic Population: A Clinicopathological Study of 130 CasesThe American Journal of Dermatopathology, 2010
- Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I–II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected databaseEuropean Journal of Cancer, 2009
- Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T‐lymphocytes and preserved MHC class I antigen expressionInternational Journal of Cancer, 2008
- Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastasesBritish Journal of Dermatology, 2007
- Cytotoxic T CellsJournal of Investigative Dermatology, 2006
- Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients with Stage III and IV MelanomaClinical Cancer Research, 2005
- Granzyme B Plays a Critical Role in Cytotoxic Lymphocyte‐induced ApoptosisImmunological Reviews, 1995
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI: Journal of the National Cancer Institute, 1989